Study on the pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in obesity-related atrial fibrillation based on network pharmacology and experimental verification.

Ann Transl Med · 2023 · PMC10170287 · PMID 37181345

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Conclusions Our study elaborated on the potential mechanisms of SGLT2i in treating obesity-related AF by methodically predicting, screening, and analyzing targets and pathways that may be significant in biological processes and further validating the findings via in vivo experiments.

also in 4,095 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.